Landfar Bio-medicine Co., Ltd (SHE:000504)
8.85
-0.45 (-4.84%)
At close: Jan 23, 2026
Landfar Bio-medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 162.82 | 207.36 | 493.81 | 218.15 | 153 | 67.04 | Upgrade |
Trading Asset Securities | 100.46 | 0.61 | 1.72 | 1.69 | 0.5 | 0.66 | Upgrade |
Cash & Short-Term Investments | 263.28 | 207.97 | 495.53 | 219.83 | 153.51 | 67.7 | Upgrade |
Cash Growth | -16.49% | -58.03% | 125.41% | 43.21% | 126.76% | -3.78% | Upgrade |
Accounts Receivable | 143.51 | 139.58 | 123.22 | 158.76 | 197.92 | 198.54 | Upgrade |
Other Receivables | 24.01 | 13.62 | 19.35 | 27.67 | 8.82 | 23.95 | Upgrade |
Receivables | 167.53 | 153.2 | 142.57 | 186.43 | 206.74 | 222.49 | Upgrade |
Inventory | 46.25 | 34.06 | 10.66 | 4.5 | 10.64 | 14.93 | Upgrade |
Prepaid Expenses | - | 0.16 | 0.07 | 0.03 | 0.57 | 0.07 | Upgrade |
Other Current Assets | 40.38 | 6.51 | 6.02 | 5.44 | 145.17 | 174.52 | Upgrade |
Total Current Assets | 517.44 | 401.9 | 654.85 | 416.24 | 516.62 | 479.7 | Upgrade |
Property, Plant & Equipment | 176.46 | 26.05 | 28.06 | 35.93 | 35.85 | 11.6 | Upgrade |
Long-Term Investments | - | 100 | 5.42 | 5.48 | 5.98 | 6.3 | Upgrade |
Goodwill | 1.98 | 1.98 | 1.98 | 8.44 | 8.44 | 11.23 | Upgrade |
Other Intangible Assets | 62.37 | 1.86 | 0.44 | 0.36 | 0.22 | 1.54 | Upgrade |
Long-Term Accounts Receivable | - | 0.03 | 0.04 | 0.06 | 0.07 | 1.85 | Upgrade |
Long-Term Deferred Tax Assets | 8.28 | 1.92 | 1.11 | 0.6 | 1.05 | 0.96 | Upgrade |
Long-Term Deferred Charges | 75.4 | 73.75 | 79.48 | 85.67 | 89.58 | 41.45 | Upgrade |
Other Long-Term Assets | 0.03 | 0.67 | - | 0.58 | 1.44 | 1.51 | Upgrade |
Total Assets | 841.96 | 608.17 | 771.38 | 553.37 | 659.25 | 556.14 | Upgrade |
Accounts Payable | 94.69 | 84.47 | 82.21 | 82.03 | 89.56 | 60.69 | Upgrade |
Accrued Expenses | 3.23 | 8.03 | 9.01 | 8.61 | 6.17 | 10.19 | Upgrade |
Short-Term Debt | 43.04 | - | 187.71 | 218.73 | 293.06 | 271.62 | Upgrade |
Current Portion of Long-Term Debt | 1.58 | 1 | - | - | - | - | Upgrade |
Current Portion of Leases | - | 3.61 | 3.16 | 2.81 | 2.35 | - | Upgrade |
Current Income Taxes Payable | 2.7 | 2.58 | 1.62 | 7.19 | 4.88 | 5.11 | Upgrade |
Current Unearned Revenue | 194.63 | 185.18 | 151.41 | 119.74 | 123.84 | 63.29 | Upgrade |
Other Current Liabilities | 24.48 | 20.61 | 17.28 | 16.04 | 9.14 | 7.37 | Upgrade |
Total Current Liabilities | 364.36 | 305.47 | 452.4 | 455.15 | 529 | 418.26 | Upgrade |
Long-Term Debt | 75.49 | 9 | - | - | - | - | Upgrade |
Long-Term Leases | 9.68 | 10.45 | 13 | 14.79 | 16.89 | - | Upgrade |
Long-Term Unearned Revenue | 23.15 | 1.1 | 1.06 | 1.83 | 1.4 | 1.22 | Upgrade |
Long-Term Deferred Tax Liabilities | 6.63 | 0.15 | 0.25 | 0.41 | 0.64 | 1.18 | Upgrade |
Other Long-Term Liabilities | - | - | - | 1 | 1 | 1 | Upgrade |
Total Liabilities | 479.3 | 326.17 | 466.71 | 473.18 | 548.93 | 421.66 | Upgrade |
Common Stock | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 | 311.57 | Upgrade |
Additional Paid-In Capital | 423.47 | 423.47 | 423.47 | 170.82 | 160.99 | 151.79 | Upgrade |
Retained Earnings | -511.17 | -516.4 | -496.55 | -468.38 | -455.92 | -436.8 | Upgrade |
Total Common Equity | 242.33 | 237.1 | 256.94 | 14.01 | 16.64 | 26.57 | Upgrade |
Minority Interest | 120.33 | 44.9 | 47.73 | 66.18 | 93.68 | 107.91 | Upgrade |
Shareholders' Equity | 362.66 | 282 | 304.67 | 80.19 | 110.32 | 134.48 | Upgrade |
Total Liabilities & Equity | 841.96 | 608.17 | 771.38 | 553.37 | 659.25 | 556.14 | Upgrade |
Total Debt | 129.78 | 24.06 | 203.87 | 236.33 | 312.29 | 271.62 | Upgrade |
Net Cash (Debt) | 133.49 | 183.91 | 291.66 | -16.5 | -158.79 | -203.92 | Upgrade |
Net Cash Growth | -53.42% | -36.94% | - | - | - | - | Upgrade |
Net Cash Per Share | 0.40 | 0.56 | 0.93 | -0.05 | -0.50 | -0.75 | Upgrade |
Filing Date Shares Outstanding | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 | 311.57 | Upgrade |
Total Common Shares Outstanding | 330.02 | 330.02 | 330.02 | 311.57 | 311.57 | 311.57 | Upgrade |
Working Capital | 153.08 | 96.43 | 202.45 | -38.92 | -12.38 | 61.44 | Upgrade |
Book Value Per Share | 0.73 | 0.72 | 0.78 | 0.04 | 0.05 | 0.09 | Upgrade |
Tangible Book Value | 177.98 | 233.25 | 254.52 | 5.21 | 7.98 | 13.79 | Upgrade |
Tangible Book Value Per Share | 0.54 | 0.71 | 0.77 | 0.02 | 0.03 | 0.04 | Upgrade |
Buildings | - | - | - | 12.94 | 12.94 | 12.94 | Upgrade |
Machinery | - | 25.09 | 23.4 | 22.39 | 16.85 | 10.75 | Upgrade |
Construction In Progress | - | - | - | - | 1.29 | - | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.